优化了CG - 6型大孔阴离子交换树脂从人血浆中吸附和分离凝血酶原复合物的工艺条件。
Technical conditions for adsorption and separation of prothrombin complex concentrates from human plasma with CG-6 macroporous anion-exchange resin were optimized.
组给予中药煎汤另服华法林钠，使血浆凝血酶原时间保持在正常的1 5倍左右；
Group A was given herbal medicine soup together with Warfarin Sodium Tablets, keeping plasma thrombinogen time at 1.5 times as normal.
结论凝血酶原突变基因20210A可能增加了胃癌的遗传易感性。
Conclusion Prothrombin 20210a gene mutation may increase genetic susceptibility of gastric cancer.
目的：探讨检测临产孕妇凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)的临床意义。
Objective: To explore clinical significance of detecting prothrombin time (PT), the activated partial thromboplastin time (APTT), thrombin time (TT), plasma fibrinogen (fib) for parturient women.
目的：探讨凝血酶原时间测定的部分影响因素。
Objective: to investigate the part influence factors of prothrombin time assay.
目的评价采用凝血酶原时间(PT)监测心脏机械型瓣膜置换术后患者口服华法林治疗效果的意义。
Objective: to monitor the curative effect of oral warfarin for the patients after heart mechanical valve displacement by the prothrombin time (PT).
大多数肝硬化腹水的患者凝血酶原时间延长并有一定程度的血小板减少。
The majority of patients with ascites due to cirrhosis have prolongation of the prothrombin time and some degree of thrombocytopenia.
诱癌早期的大鼠血浆即出现了高水平异常凝血酶原，它可用于肝癌的早期诊断。
In contrast, there wag no abnormal prothrombin in the rat plasma during its liver regeneration.
目的探讨严重多发伤患者血浆凝血酶原片段1+2（F1+2）水平变化及与创伤后弥散性血管内凝血（D IC）之间的关系。
Objective To explore the relationship between traumatic DIC and level of plasma thrombinogen segment 1+2(F1+2) in severe multi-injury patients.
目的研究血清胆碱酯酶(CHE)、凝血酶原活动度(PTA)与病毒性肝炎临床分型、病情及预后之间的关系。
Objective To investigate the relationship between serum cholinesterase (CHE), prothrombin activity (PTA) and the clinical type, disease condition and prognosis in the viral hepatitis patients.
目的探讨米非司酮对血小板、血浆凝血酶原时间的影响。
Objective to explore effects of blood platelets and prothrombin time on mifepristone.
目的探讨不同的抗凝血体外贮存条件对凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）的影响。
Objective To investigate the effects of different storage temperatures on anticoagulated blood hemagglutination tests, including prothrombin time(PT), and activated partial thromboplastin time(APTT).
目的：利用正常血浆和定标血浆，建立一种准确可靠、易于实验室开展的凝血酶原时间国际标准化比值检测方法。
Objectives: Using normal plasmas and criterion plasmas to establish a kind of accurate and feasible method that could measure international normalized ratio (INR) of prothrombin time (PT).
目的探讨临产孕妇血小板、凝血酶原时间、活化部分凝血活酶时间、凝血酶时间、纤维蛋白原检测的临床意义。
Objective To explore the clinical significance of platelet, prothrombin time , activated partial thromboplastin time , thrombin time , plasma fibrinogen for parturient women.
目的：研究凝血酶原活性与肝硬化病人预后的关系。
Objective: To study the relationship between prothrombin coagulative activity and the prognosis of patients with liver cirrhosis.
目的研究几种常见的癌症患者血浆凝血酶原时间（PT）、凝血酶时间（TT）、活化部分凝血酶时间（APTT）、纤维蛋白原（FIB）测定的临床价值。
Objective To study the clinical value of detecting several common cancer patients' protothrombin time(PT), thrombin time (TT), active part thrombin time(APTT) and fibrinogen(FIB).
目的通过对国产人凝血酶原复合物(PCC)质量的研究，建立与国际接规的质量标准。
PurposeTo study on the quality of human prothrombin complex concentrate so as to establish the same quality standard as the international standard of PCC.
常用化疗药环磷酰胺能损伤机体的凝血系统，导致大鼠凝血酶原时间和部分凝血酶原时间的延长。
The common chemotherapy medicine cytoxan (CTX) can damage the body's coagulation and prolong the PT and KPTT time.
考察了其对血浆中总蛋白和凝血酶原复合物的吸附情况及吸附等温线，以及影响凝血酶原复合物活性的因素。
The adsorption behaviors and adsorption isothermals of total proteins and prothrombin complex concentrates and the effect factors on activity of prothrombin complex concentrates were investigated.
目的：制备结合凝血酶原复合物(PCC)的阴离子脂膜微泡，评价微泡的理化性质。
Purpose: the purpose of this study is to prepare prothrombin complex concentrate (PCC) conjugated anionic lipid microbubbles and to assess the physiochemical properties of the microbubbles.
前言： 目的：自制凝血酶原片段F1+2单克隆抗体，探讨其在血栓性疾病中的诊断作用。
Objective:To prepare a monoclonal antibody against prothrombin fragment 1+2(F1+2) and study its diagnostic effect in patients with thromboembolism.
目的探讨根据凝血酶原活动度（PTA）预测重型肝炎高胆红素血症行血浆置换的临床疗效。
Objective To evaluate the treatment of plasma exchange(PE) in patients with chronic severe hepatitis based on prothrombin activity(PTA).
方法：用干粉试剂和液体试剂在同一台全自动血凝仪测定病人标本与健康人标本凝血酶原时间与INR的结果，应用统计学方法对测定结果进行分析。
Methods: The PT and INR were measured by dry reagent and liquid reagent in same Automated Blood Coagulation Analyzer in patients and healthy people, Analyze results with statistical methods.
目的探讨肝硬化指标白蛋白(ALB)，凝血酶原时间(PT)，总胆红素(TBIL)，总胆汁酸(TBA)等四项指标对肝硬化诊断的临床意义。
Objective to investigate the clinical significance of detecting albumin (alb) plasma prothrombin coagulative time (PT), total bilirubin (TBIL) and total bile acid (TAB) on liver cirrhosis.
目的探讨肝硬化指标白蛋白(ALB)，凝血酶原时间(PT)，总胆红素(TBIL)，总胆汁酸(TBA)等四项指标对肝硬化诊断的临床意义。
Objective to investigate the clinical significance of detecting albumin (alb) plasma prothrombin coagulative time (PT), total bilirubin (TBIL) and total bile acid (TAB) on liver cirrhosis.
应用推荐